Goat Anti-Syrian Hamster IgG H&L (HRP) (ab6892)
Key features and details
- Goat Anti-Syrian Hamster IgG H&L (HRP)
- Conjugation: HRP
- Host species: Goat
- Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IF
Related conjugates and formulations
製品の概要
-
製品名
Goat Anti-Syrian Hamster IgG H&L (HRP)
IgG 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Syrian hamster -
アプリケーション
適用あり: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IFmore details -
免疫原
Full length native hamster IgG (purified).
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.424% Potassium phosphate, 0.87% Sodium chloride, 1% BSA -
Concentration information loading...
-
精製度
Affinity purified -
特記事項(精製)
This product was prepared from monospecific antiserum by immunoaffinity chromatography using hamster IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
特記事項(標識)
Horseradish Peroxidase (HRP) -
ポリ/モノ
ポリクローナル -
研究分野
関連製品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab6892の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
Dot blot |
Use at an assay dependent dilution.
|
|
ELISA |
1/7000 - 1/35000.
|
|
IHC-P |
Use at an assay dependent dilution.
|
|
IHC-Fr |
Use at an assay dependent dilution.
|
|
Immunomicroscopy |
Use at an assay dependent dilution.
|
|
WB |
1/1000 - 1/5000.
|
|
ICC/IF |
1/500 - 1/2500.
|
特記事項 |
---|
Dot blot
Use at an assay dependent dilution. |
ELISA
1/7000 - 1/35000. |
IHC-P
Use at an assay dependent dilution. |
IHC-Fr
Use at an assay dependent dilution. |
Immunomicroscopy
Use at an assay dependent dilution. |
WB
1/1000 - 1/5000. |
ICC/IF
1/500 - 1/2500. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (6)
ab6892 は 6 報の論文で使用されています。
- Burchill MA et al. Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. Cell Mol Gastroenterol Hepatol 11:573-595 (2021). PubMed: 32961356
- Nagai M et al. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. mBio 12:e0159821 (2021). PubMed: 34399617
- Walpita P et al. A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model. NPJ Vaccines 2:21 (2017). PubMed: 29263876
- Sharma G et al. Purification and characterization of adenovirus core protein VII: a histone-like protein that is critical for adenovirus core formation. J Gen Virol 98:1785-1794 (2017). PubMed: 28695796
- Huang Y et al. Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice. PLoS One 9:e91850 (2014). PubMed: 24637805
- Hoffhines AJ et al. Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo. J Biol Chem 284:3096-105 (2009). PubMed: 19047058